While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Cash flow is valuable, but it’s not everything - StockStory helps you identify the companies that truly put it to work. Keeping that in mind, here is one cash-producing company that leverages its financial strength to beat its competitors and two that may face some trouble.

Two Stocks to Sell:

Dine Brands (DIN)

Trailing 12-Month Free Cash Flow Margin: 6.1%

Operating a franchise model, Dine Brands (NYSE: DIN) is a casual restaurant chain that owns the Applebee’s and IHOP banners.

Why Do We Pass on DIN?

1. Lagging same-store sales over the past two years suggest it might have to change its pricing and marketing strategy to stimulate demand
2. Expenses have increased as a percentage of revenue over the last year as its operating margin fell by 4.3 percentage points
3. 7× net-debt-to-EBITDA ratio makes lenders less willing to extend additional capital, potentially necessitating dilutive equity offerings

Dine Brands is trading at $29.69 per share, or 6.2x forward P/E. Read our free research report to see why you should think twice about including DIN in your portfolio.

Corcept (CORT)

Trailing 12-Month Free Cash Flow Margin: 18.6%

Focusing on the powerful stress hormone that affects everything from metabolism to immune function, Corcept Therapeutics (NASDAQ: CORT) develops and markets medications that modulate cortisol to treat endocrine disorders, cancer, and neurological diseases.

Why Is CORT Not Exciting?

1. Earnings per share fell by 6.9% annually over the last five years while its revenue grew, showing its incremental sales were much less profitable
2. 27.1 percentage point decline in its free cash flow margin over the last five years reflects the company’s increased investments to defend its market position
3. Diminishing returns on capital suggest its earlier profit pools are drying up

Corcept’s stock price of $45.94 implies a valuation ratio of 122.8x forward P/E. Check out our free in-depth research report to learn more about why CORT doesn’t pass our bar.

One Stock to Watch:

Thermon (THR)

Trailing 12-Month Free Cash Flow Margin: 10.5%

Creating the first packaged tracing systems, Thermon (NYSE: THR) is a leading provider of engineered industrial process heating solutions for process industries.

Why Do We Like THR?

1. Market share has increased this cycle as its 12.4% annual revenue growth over the last five years was exceptional
2. Operating margin improvement of 8.8 percentage points over the last five years demonstrates its ability to scale efficiently
3. Incremental sales over the last five years have been highly profitable as its earnings per share increased by 46.1% annually, topping its revenue gains

At $54.08 per share, Thermon trades at 25x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it's flagging for this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.